DDW Turning Science into Business Symposium features expert panel: Watch now
Technology, market forces and new ways of working – the challenges facing drug discovery and how to overcome them: This was the topic of the panel discussion at the DDW Turning Science into Business Symposium which took place at the Francis Crick Institute in London on Tuesday 4 November.
The on-demand version of the DDW Turning Science into Business Symposium is only available for a limited time! Register now to watch before December 24th!
The expert panel included:
- Joanne Taylor, SVP Research, Gain Therapeutics
- Nadine Clemo, VP Global Program Leader, Apollo Therapeutics
- Dr Cathy Tralau-Stewart, Executive Director of The Milner Therapeutics Institute, University of Cambridge.
The audience also heard presentations from:
- Dr Daniil Bash, Lead Scientist at the Innovation Centre in Digital Molecular Technologies (iDMT), University of Cambridge
- Nikhil Gupta, Principal Scientist at the Cancer Research Horizons – AstraZeneca Functional Genomics Centre
- Lawrence Welch, Inside Sales Specialist, Nuclera
- Chas Bountra, Pro-Vice-Chancellor for Innovation, Professor of Translational Medicine, Oxford University
- Dr Cathy Tralau-Stewart, Executive Director of The Milner Therapeutics Institute, University of Cambridge
- Professor Emma Mead, Chief Scientific Officer of the Alzheimer’s Research UK Oxford Drug Discovery Institute
The event was sponsored by Nuclera (lead sponsor) and Collaborative Drug Discovery (coffee break sponsor) and Thermo Fisher Scientific (sponsor).
